PMID- 18695328 OWN - NLM STAT- MEDLINE DCOM- 20080923 LR - 20191210 IS - 0255-0857 (Print) IS - 0255-0857 (Linking) VI - 26 IP - 3 DP - 2008 Jul-Sep TI - Mycobacterial culture of fine needle aspirate - a useful tool in diagnosing tuberculous lymphadenitis. PG - 259-61 AB - A prospective study was undertaken on suspected lymph node TB (LNTB) patients, to evaluate the diagnostic utility of mycobacterial culture of fine needle aspirate (FNA), in comparison with the cytological examination and acid fast staining. Eighty percent of 157 aspirates studied were positive by cytological examination; 18% by ZN smear and 45% were positive by culture. Twelve aspirates which were negative by cytological features yielded positive mycobacterial cultures; four out of these were from HIV positive patients. Our observations suggest that supplementing FNA cytology with mycobacterial culture would increase the sensitivity of diagnosing LNTB; in addition to giving a highly specific diagnosis. FAU - Kishore Reddy, V C AU - Kishore Reddy VC AD - Blue Peter Research Center-LEPRA Society, Hyderabad, India. FAU - Aparna, S AU - Aparna S FAU - Prasad, C E AU - Prasad CE FAU - Srinivas, A AU - Srinivas A FAU - Triveni, B AU - Triveni B FAU - Gokhale, S AU - Gokhale S FAU - Krishna Moorthy, K V AU - Krishna Moorthy KV LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Indian J Med Microbiol JT - Indian journal of medical microbiology JID - 8700903 SB - IM MH - Biopsy, Fine-Needle MH - HIV Infections/complications MH - Humans MH - Mycobacterium/*isolation & purification MH - Prospective Studies MH - Sensitivity and Specificity MH - Tuberculosis, Lymph Node/*diagnosis EDAT- 2008/08/13 09:00 MHDA- 2008/09/24 09:00 CRDT- 2008/08/13 09:00 PHST- 2008/08/13 09:00 [pubmed] PHST- 2008/09/24 09:00 [medline] PHST- 2008/08/13 09:00 [entrez] AID - 10.4103/0255-0857.42040 [doi] PST - ppublish SO - Indian J Med Microbiol. 2008 Jul-Sep;26(3):259-61. doi: 10.4103/0255-0857.42040.